Molecular types and neoadjuvant chemotherapy in patients with breast cancer- while molecular shifting is more common in luminal a tumors, the pathologic complete response is most frequently observed in her-2 like tumors. [electronic resource]
Producer: 20150722Description: 9379-83 p. digitalISSN:- 2476-762X
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- metabolism
- Biopsy, Needle
- Breast Neoplasms -- drug therapy
- China
- Databases, Factual
- Female
- Follow-Up Studies
- Humans
- Immunohistochemistry
- Neoadjuvant Therapy -- methods
- Neoplasm Invasiveness -- pathology
- Neoplasm Staging
- Receptor, ErbB-2 -- metabolism
- Receptors, Estrogen -- analysis
- Receptors, Progesterone -- analysis
- Retrospective Studies
- Risk Assessment
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.